Vilobelimab
Catalogue number:
HY-P99520-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
COVID-19-anti-virus
Target:
Complement System;SARS-CoV
Alternative Names:
CaCP-29, IFX-1
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. Vilobelimab acts as a C5a inhibitor, inhibiting neutrophil activation, chemotaxis, and reducing inflammatory signalling, and may be used in studies related to sepsis, COVID-19, etc[1].